Psyched Wellness To Commence Trading Today

Psyched Wellness (CSE: PSYC) is the latest mushroom issue to hit the CSE, with the company set to begin trading today as per a bulletin filed by the exchange last night. The company is focused on health supplements, and is said to be “dedicated to the distribution of mushroom-derived products and associated consumer packaged goods.”

Presently, Psyched appears to be focused on the emerging functional food category, with a heavy focus on that of mushroom-derived products as a means of meeting its mission of providing products that promote stress relief and relaxation, assist with sleeping and supporting mood. The firm is said to currently be in the process of developing several products in the category, which included muscaria-derived teas, capsules and water-based extracts.

In terms of product development, it appears the company initiated research and development on the use of Amanita Muscaria as a functional mushroom supplement in the first quarter of 2020. From here, the company then completed an extraction protocol for the compound which will be used to commence pre-clinical trials on the extract as well as a product license application (PLA).

The company deck identifies that the function mushroom market is currently forecasted to hit US$34.3 billion by 2024, with a compound annual growth rate of 8.04%.

Selkirk Copper Mines — sponsored Sponsored · Selkirk Copper Mines

Perhaps one of the currently most notable aspects of Psyched Wellness is the leadership team behind it. Lead by CEO Jeff Stevens whom has over two decades of capital markets experience, Stevens has managed to assemble a notable board of directors, which contains current executives of Juul Labs Canada, as well as the former CEO and founder of Aurora Cannabis (TSX: ACB) (NYSE: ACB) Terry Booth.

In terms of share structure, Psyched Wellness presently has 104,642,930 common shares outstanding, with an additional 9,681,200 reserved for issuance. With the latest round of financing occurring at $0.10, the company is expected to hit the market with a capitalization of roughly $10.4 million.

Psyched Wellness is set to begin trading today under the symbol “PSYC” on the Canadian Securities Exchange.


Information for this briefing was found via Sedar and the companies mentioned. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Gold, Silver & the $1.48 Quadrillion Derivatives Threat | Lynette Zang – Zang International

These Mining Stocks Have Huge Upside… But Here’s the Catch | Oct. 19-23 – Weekly Mining Mailbag

Selkirk Copper: Why The PEA Discount?

Recommended

Blue Jay Gold Signs Ocean Partners Deal to Ship Steller Stockpiles Through 2027

Krait Critical Minerals Signs Option for Historical Nevada King Antimony Mine

Related News

Psyched Wellness Sees Professor David Nutt Move From Advisory Role To Directorship

It appears that Professor David Nutt has a desire to become more involved with that...

Monday, November 16, 2020, 08:11:48 AM

Psyched Wellness Signs Two Year Supply Agreement For Amanita Muscaria

Psyched Wellness (CSE: PSYC) this morning had a brief announcement. Within, the company revealed that...

Tuesday, May 4, 2021, 08:36:07 AM

Compass Pathways Leader Of Investment Climate For Psychedelic Plays – The Daily Dive feat Jeff Stevens

Today on the Daily Dive, Jeff Stevens returns to the show to sit down with...

Wednesday, December 30, 2020, 01:30:00 PM

Psyched Wellness Announces Study On Muscimol Antioxidant and Anti-Inflammatory Properties

Psyched Wellness (CSE: PSYC) has begun yet another study related to that of the Amanita...

Wednesday, January 6, 2021, 07:48:08 AM

Psyched Wellness Adds Amanita Muscaria Expert To Advisory Board

Kevin Feeney has joined the advisory board of that of Psyched Wellness (CSE: PSYC) as...

Thursday, November 26, 2020, 07:16:39 AM